Clin2
NCT07708818Possibly a fitNot yet recruiting

AI heart check after atrial fibrillation treatment

Atrial Fibrillation (AF)Heart Failure With Mildly Reduced Ejection Fraction (HFmrEF)

Part of Heart & circulation clinical trials.

This trial uses an artificial intelligence tool to read your heart's electrical signals and check how well your heart is recovering after a procedure to fix an irregular heartbeat called atrial fibrillation. It aims to find early signs of heart failure and guide better care.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
1,000 people
Ages
18 years and older
Study type
Observational

Who can take part

  • You are 18 years or older.
  • You have atrial fibrillation that causes symptoms and comes and goes or is persistent.
  • This is your first time having a catheter ablation procedure for atrial fibrillation.
  • Your heart's pumping strength is slightly reduced, between 41% and 49%.
  • You have at least one sign of early heart failure, like a high NT-proBNP blood test, an enlarged left upper heart chamber, or trouble breathing with activity.
  • You do not have severe heart valve disease, certain heart muscle diseases, recent heart attack or heart surgery, severe kidney disease, or active cancer.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07486739Not yet recruiting
AI-assisted heart function check for atrial fibrillation management

This study uses an artificial intelligence (AI) tool to read your heart's electrical activity (ECG) to help doctors better manage your atrial fibrillation (AFib), an irregular heartbeat that can increase stroke risk. By combining the ECG with a heart ultrasound (echocardiogram), the AI aims to improve treatment decisions and outcomes.

Ansan
NCT07844434Not yet recruiting
AI heart analysis with standard and simple ECGs

This study tests whether artificial intelligence (AI) can analyze heart signals from a standard 12-lead ECG and a simpler 1-lead ECG. Participants will have an extra ECG taken during their regular visit, which takes just a few extra minutes and helps doctors learn if AI can spot heart issues from a simpler test.

Incheon, Incheon
NCT07069998Not yet recruiting
AI-guided treatment for atrial fibrillation

This trial tests an AI-guided approach to treating atrial fibrillation (AF), a heart rhythm problem. It aims to personalize your treatment plan to better manage symptoms and improve outcomes.

NCT06847932Recruiting
AI ECG to detect early atrial fibrillation

This trial uses an artificial intelligence system to analyze your electrocardiogram (ECG) results and alert your care team if you might be developing atrial fibrillation. It aims to catch this common heart rhythm problem early, so you can get treatment sooner.

Taipei
NCT06842147Recruiting
AI Heart Monitor for New Atrial Fibrillation Detection

This trial uses a special long-term heart monitor (one wire) that uses artificial intelligence to find new cases of atrial fibrillation, a type of irregular heartbeat that can increase stroke risk. If you're 60 or older and haven't had AF before, this study could help catch it early.

Zhejiang, Quzhou
NCT07722078Not yet recruiting
Smart heart monitor to predict irregular heartbeat early

This study is testing an artificial intelligence (AI) tool that uses a simple single-lead ECG (heart rhythm recording) to predict whether a patient will develop atrial fibrillation (a common heart rhythm problem) within the next 2 hours. The goal is to help doctors detect and treat this condition earlier, potentially preventing complications.

Hear when a new Atrial Fibrillation (AF) trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.